International Journal of Women's Health
Open access peer-reviewed scientific and medical journals.
Dove Medical Press is now a member of the Open Access Initiative
An Author's Guide
A guide to help authors get their paper published.
Support Open Access and Dove Press
Promotional Article Monitoring - further details
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Optimal management of nausea and vomiting of pregnancy
(10219) Total Article Views
Authors: Neda Ebrahimi, Caroline Maltepe, Adrienne Einarson
Published Date August 2010
Volume 2010:2 Pages 241 - 248
Neda Ebrahimi1,2, Caroline Maltepe2, Adrienne Einarson2
1Pharmaceutical Sciences, University of Toronto, Toronto, Ontario, Canada; 2Motherisk Program, The Hospital for Sick Children, Toronto, Ontario, Canada
Abstract: Nausea and vomiting of pregnancy (NVP) is a common medical condition in pregnancy with significant physical and psychological morbidity. Up to 90% of women will suffer from NVP symptoms in the first trimester of pregnancy with up to 2% developing hyperemesis gravidarum which is NVP at its worst, leading to hospitalization and even death in extreme cases. Optimal management of NVP begins with nonpharmacological approaches, use of ginger, acupressure, vitamin B6, and dietary adjustments. The positive impact of these noninvasive, inexpensive and safe methods has been demonstrated. Pharmacological treatments are available with varying effectiveness; however, the only drug marketed specifically for the treatment of NVP in pregnancy is Diclectin® (vitamin B6 and doxylamine). In addition, the Motherisk algorithm provides a guideline for use of safe and effective drugs for the treatment of NVP. Optimal medical management of symptoms will ensure the mental and physical wellbeing of expecting mothers and their developing babies during this often stressful and difficult time period. Dismissing NVP as an inconsequential part of pregnancy can have serious ramifications for both mother and baby.
Keywords: pharmacological/nonpharmacological treatments, NVP
A Letter to the Editor has been received and published for this article.
Cannotea Citeulike Del.icio.us Facebook LinkedIn Twitter
Readers of this article also read:
"You do a tremendous job!!" Ruben Restrepo, University of Texas Health Science Center, San Antonio.
- Tinidazole in the treatment of bacterial vaginosis
- Contraceptive practices in Nigeria: Literature review and recommendation for future policy decisions
- Diagnosis and management of pre-eclampsia: an update
- Antibacterial treatment of bacterial vaginosis: current and emerging therapies